Inhibition of fatty acid synthase by amentoflavone suppresses HER2/neu (erbB2) oncogene expression in breast cancer cells

被引：0
|
作者：
Chang, E. [1 ,2 ]
Lee, J. [3 ]
Lee, M. [4 ]
Cha, E. [4 ]
Sul, J. [1 ,2 ]
Byun, W. [3 ]
机构：
[1] Chungnam Natl Univ, Sch Med, Dept Surg, Taejon, South Korea
[2] Chungnam Natl Univ, Res Inst Med Sci, Taejon, South Korea
[3] Chungnam Natl Univ Hosp, Dept Surg, Taejon, South Korea
[4] Chungnam Natl Univ Hosp, Reg Canc Inst, Taejon, South Korea
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70442-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [11] Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer
    Schroeder, Richard L.
    Stevens, Cheryl L.
    Sridhar, Jayalakshmi
    MOLECULES, 2014, 19 (09) : 15196 - 15212
  • [12] Oleic acid suppresses overexpression of ERBB2 oncogene
    Nelson, R
    LANCET ONCOLOGY, 2005, 6 (02): : 69 - 69
  • [13] ERBB2 (HER2/NEU) ONCOGENE IS FREQUENTLY AMPLIFIED IN SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX
    MITRA, AB
    MURTY, VVVS
    PRATAP, M
    SODHANI, P
    CHAGANTI, RSK
    CANCER RESEARCH, 1994, 54 (03) : 637 - 639
  • [14] Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells
    Jeong, Jaekwang
    Choi, Jungmin
    Kim, Wonnam
    Dann, Pamela
    Takyar, Farzin
    Gefter, Julia V.
    Friedman, Peter A.
    Wysolmerski, John J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (03) : 887 - 901
  • [15] Prognostic and predictive value of HER2/neu oncogene in breast cancer
    Masood, S
    Bui, MM
    MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 59 (02) : 102 - 108
  • [16] Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene
    Harbeck, Nadia
    Pegram, Mark D.
    Rueschoff, Josef
    Moebus, Volker
    BREAST CARE, 2010, 5 : 3 - 7
  • [17] The HER2/neu (erbB2) polymorphism, body mass index, and the risk of endometrial cancer
    Lee, J.
    Tong, S.
    Lee, K.
    Kim, J.
    Kwon, Y.
    Kim, J.
    Kim, Y.
    Yei, J.
    Do, Y.
    Kwon, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [18] Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
    Harari, D
    Yarden, Y
    ONCOGENE, 2000, 19 (53) : 6102 - 6114
  • [19] Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
    Daniel Harari
    Yosef Yarden
    Oncogene, 2000, 19 : 6102 - 6114
  • [20] Future options in the treatment of ErbB2 (HER2)-positive breast cancer
    Fumoleau, Pierre
    EJC SUPPLEMENTS, 2008, 6 (05): : 25 - 31
12345